Video Gallery

Please see Dyadic’s YouTube Channel for more Videos

Dyadic and VTT Are Developing an Efficient New Production Method for Covid-19 Vaccines - September 2020
A Brief Look into Dyadic's Past and What the Future May Bring - September, 2020
Noble Capital Markets
Channelcheck c-suite series One-on-one with President & CEO Mark Emalfarb - June 24, 2020
Dyadic working with global research partners to express potential coronavirus vaccines using C1, May 15, 2020
Planet MicroCap Showcase 2020 Panel Discussion on Coronavirus Pandemic
Ping Rawson, CFO invited guest with MSQ Ventures - Fighting Virus Pandemics: The Now and The Future - Expert’s Perception of Challenges & Opportunities
February 27, 2020
Trish Regan Primetime. Fox Business - Dyadic International (Nasdaq:DYAI) CEO Mark Emalfarb discusses how his company could expedite the production of an affordable coronavirus vaccine.
Mark Emalfarb, CEO (Nasdaq:DYAI) on YAHOO Finance On The Move to discuss the spread of Coronavirus February 4, 2020
Mark Emalfarb / TD Ameritrade Interview “The Watch List” February 11, 2020
#TradeTalks: Getting Ahead of the Curve on Pandemic & Biological Threats with Synthetic Biology February 2020
Dyadic Getting Ahead of the Curve on Coronavirus Cure, CEO Says January 31, 2020
Dyadic CEO Mark Emalfarb interviewed by Liz Claman “The Claman Countdown” from FOX Business Network - Monday, January 27, 2020
Dyadic CEO remarks on steps the federal gov't can take to speed along drug manufacturing January 2020
Dyadic International reveals recent 4Q highlights and upcoming milestones January 2020
Dyadic International, Inc. (OTCQX: DYAI) The Innovation Show – August 2017 | From Stonewashed Jeans to Lifesaving Genes
Dyadic Seeks to Bring Disruptive Technology to Biomanufacturing, The Bio Report, June 2017